⚕ GalenOps field
←

709-1168

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
709 (USA) · Dr. Novak
consented 2013-08-02

AEs
6
Serious
0
Dropout signal
–

Adverse events

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE

moderate assessed

Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE

moderate assessed

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE

moderate assessed

Moderate RASH — outcome: RECOVERED/RESOLVED; onset 2013-09-06 (study day 36.0); relationship: PROBABLE

mild assessed

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-08-17 (study day 16.0); relationship: PROBABLE

mild assessed

Mild SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-08-17 (study day 16.0); relationship: PROBABLE

Data queries

No data queries.